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Background: A strong inverse relationship of functional limitation and socioeconomic status has been established
in western ageing society. Functional limitation can be related to chronic diseases, disuse, cognitive decline, and
ageing. Among chronic diseases in the Thai population, cerebrovascular diseases, diabetes, and arthritis are
common. These factors are known to contribute to disability and poor quality of life in the elder population.
Neuropsychiatric problems, cognitive decline, dementia, and cultural issues in elderly people also can alter the
quality of life of the elderly.
Methods: The Dementia and Disability Project in Thai Elderly (DDP) aims at comprehensively assessing community
dwelling Thai elderly to understand the relationship between disability and motor function, neuropsychiatric
symptoms, cognitive function, and chronic diseases. The DDP is the first study to look at the prevalence and
etiology of dementia and of mild cognitive impairment (MCI) in Thai elders and to explore the relationship of
cognition, disability, small vessel diseases and cortical degeneration with neuroimaging in Thai elderly people. 1998
Thai elders were screened in 2004–2006 and diagnosed as having MCI or dementia. 223 elders with MCI or
dementia and cognitively normal elderly had brain magnetic resonance imaging (MRI) or at baseline. 319 elders
from the 3 groups had blood tests to investigate the risks and possible etiologies of dementia including
genotyping at baseline.
Results: The mean age of elders in this study is 69.51(SD=6.71, min=60, max=95) years. 689(34.9%) are men and
1284(65.1%) are women. Mean body weight was 58.36(SD=11.20) kgs. The regression model reveals that
performance on gait and balance and serum triglyceride predicts activity of daily living performance (adjusted
r2 = 0.280, f=2.644, p=0.003). The majority of abnormal gait in Thai elders was lower level gait disturbance. Only
1.5% (29/1952) had highest level gait disorders. 39.5% of 1964 subjects were free of chronic diseases. Treatment gap
(indicating those who have untreated or inadequate treatment) of diabetes mellitus and hypertension in Thai elders
in this study was 37% and 55.5% respectively. 62.6% of Thai elders have ApoE3E3 allele. Prevalence of positive
ApoE4 gene in this study is 22.85%. 38.6% of Thai elders who had MRI brain study have moderate to severe white
matter lesions.
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Conclusion: The large and comprehensive set of measurements in DDP allows a wide-ranging explanation of the
functional and clinical features to be investigated in relation to white matter lesions or cortical atrophy of the brain
in Thai elderly population. An almost 2 year follow up was made available to those with MCI and dementia and
some of the cognitively normal elderly. The longitudinal design will provide great understanding of the possible
contributors to disability in the elderly and to the progression of cognitive decline in Thai elders.
Keywords: Mild cognitive impairment, Dementia, Alzheimer disease, Disability, White matter lesions, ThailandBackground
Thailand has been an ageing society with older persons
constituting more than 10 percent of the population
since 2002. One of the important chronic diseases of
Thai elderly population is dementia. The contributions
of dementia and mild cognitive impairment (MCI) to
disability in Thai elderly are unknown. Determining the
causes of disability as well as the role of dementia and
MCI in producing disability has major public health
implications. Planning resource use, assisting families to
cope and understanding reversible causes of disability
are important application of this information. Deep cere-
bral small vessel disease caused by aging, arterial hyper-
tension, diabetes mellitus, smoking and other factors is a
vasculopathy leading to mobility problems and to dis-
ability [1,2]. Functional and clinical abnormalities in
patients with cerebral small vessel disease, shown as
white matter hyperintensities (WMHs) or white matter
lesions (WMLs) in brain magnetic resonance imaging
(MRI), have shown an association with global or selective
cognitive deficits, depression, and motor abnormalities
[3]. These features can contribute to disability in the eld-
erly. Certain cognitive deficits, for example, slowing of
processing time and executive dysfunction could give rise
to difficulties in personal and social activities [4]. Motor
deficits, including rigidity, gait apraxia and impaired bal-
ance on walking, increase risk of falls [5]. Physical illness
such as back pain or osteoarthritis of the knees can also
cause mobility problems. Disabilities in daily function and
in general health are a possible consequence of an inter-
action between cognition, neuropsychiatric disorders, and
chronic diseases in elderly persons.The dementia and disability project (DDP) on Thai
elderly: rationale
An increase in interest in the burden of chronic and dis-
abling health conditions that are not necessarily fatal has
been growing in developing countries [6]. Few measures
including the prevalence, disabilities and impairments
related to the disorders, mortality and costs can indicate
the full burden of such diseases [7]. In Thailand, there
has been no epidemiology data on etiology of dementia
or MCI in a community cohort. Understanding physicaland mental health status of Thai elderly with and with-
out disability will assist the formation of public health
policy and response to the needs of social welfare for the
elderly [8,9]. Longitudinal follow up can demonstrate the
dynamic of these interactions. Epidemiological studies
including brain imaging in Thai elderly can explain the
natural history of the motor and mental disability from
the biological point of view [10]. This may possibly lead
to a preventive strategies based on scientific information.
This report aims to introduce the project and its back-
ground. This is a preliminary analysis of important base-
line information and the associations between daily
function and vascular risk factors from the Dementia and
Disability Project (DDP). Future analyses on other issues
from the DDP study are planned.Objectives
The specific aims of the DDP in Thai elderly are: 1) De-
termine the frequency of dementia, MCI and disability
including Alzheimer disease (AD) as causes of disabil-
ities in the Thai elderly community-dwelling cohort. 2)
Determine the cause of dementia in elderly individuals.
3) Determine the incidence of dementia during a total
follow-up period of 1–2 years on patients with MCI. 4)
Determine the variance in disability of dementias contrib-
uted by behavioral disturbances and determine the rela-
tionship between functional disability, neuropsychiatric
problems and quality of life in Thai elderly. 5) Explore the
relationship between white matter lesions in brain imaging
to functional autonomy disability, dementia, and depres-
sion in Thai elderly subjects. 6) Develop educational strat-
egies or community service program for exporting this
dementia and disability screening technique to other
catchment areas in Bangkok or in other provinces.
Methods
We screened Thai elders age 60 and above living in 42
villages in the catchment areas of the primary care unit
(PCU) of Siriraj Hospital in late 2004-early 2006. The
screening consisted of a comprehensive geriatric assess-
ment to determine health status, functional status, cognitive
function, mobility and balance, and possible disabilities.
According to Persons with Disabilities Empowerment Act
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domains: vision, hearing, daily function, neuropsychiatric
issues, and cognition. We used a modified, culturally
adapted Mini Mental State Examination (MMSE) called
Thai Mental State Examination (TMSE) [11], Thai Activity
of Daily Living (ADL) [12], Neuropsychiatric Inventory
Questionnaire (NPI-Q) [13,14], Clinical dementia rating
scale (CDR) [15], Thai Geriatric Depression Scale (TGDS)
[16], Tinetti gait assessment [17], timed-get up and go test
[18], standard neuropsychological tests [19-26] with cultur-
ally adjusted norms including tests of attention, memory,
executive function, visuospatial function, and naming tasks.
Hearing was assessed by standard audiometry. Profound
hearing loss is described as being unable to hear a >90 deci
Bell in the better ear. Visual acuity was assessed by using a
pocket Jager chart. Severely impaired eyesight or blindness
is defined by having corrected visual acuity <20/400 in both
eyes. World Health Organization (WHO) quality of life was
used to assess general health [27]. History of falls in the
past 1 month was recorded. All is defined by a sudden, un-
intentional change in position causing an individual to land
at a lower level, on an object, the floor, the ground or other
surface and having part of the body touching the ground.
We diagnosed dementia by Diagnostic and Statistical Man-
ual (DSM) IV criteria [28] and MCI by modified Petersen’s
criteria [29]. SPSS 11 was used for statistical analysis. Blood
tests to analyze possible reversible causes of dementia and
ApoE gene status, brain MRI were offered to those with
MCI, dementia and to 30 cases of normal elders to evaluate
the cause of dementia and its comorbidity.
The DDP planned to follow individuals with MCI and
dementia at 1–2 year interval and to follow 5-10% of
individuals with non-dementia non MCI (non-case
group) for the same period. At the follow up assessment,
the cognition, function, and neuropsychiatric problems
were reassessed.Subjects
Sample size estimation based on detecting progression
from MCI to demetia is calculated by assuming that preva-
lence of MCI is 15%, prevalence of MCI progression is
12%, 2-sided of 95% confidence interval and allowable
error is 4%. Therefore, a sample size of MCI should be 254
and the studied population should be 1,694 (Computer
program – n Query Advisor). If there is 15% drop out, then
the sample size would be 1,948.
The DDP have been performed with the approval
from the Ethics Committee on Research Involving
Human Subject of Faculty of Medicine Siriraj Hospital,
Mahidol University (No.141/2003). Written informed
consent for participation in the study was obtained
from both participants and their relatives either
spouse or children.Inclusion
Inclusion criteria are as follows:
1. Elderly persons age 60 and above who register to
obtain primary care service at the PCU of Siriraj
Hospital.
2. Elderly persons and caregivers who agree to
participate with the study for the 3 year period.
3. Elderly persons who live within 20 kilometers from
Siriraj Hospital.
Exclusion
Exclusion criteria are as follows:
1. Elderly persons or caregivers who do not wish to join
the DDP study or are unable to give an informed
consent.
2. Elderly persons who drop out because of the
presence of severe illnesses (cardiac, hepatic or renal
failure, cancer or other relevant systemic diseases) at
the follow up, and who have severe illnesses at
baseline and refuse to participate with the DDP
study.
3. Severe psychiatric disorders.
Baseline assessment
A structured and comprehensive questionnaire was
administered by trained personnel to the patient and
care partner and included information on demographic
characteristics, education, occupational status defined
as longest job in life, marital status, living conditions,
lifestyle habits (alcohol consumption, smoking), vascu-
lar risk factors and current medical problems. Elders
and caregivers were purposely asked if elders had any
memory complaint or similar problem. Blindness and
severe hearing loss were determined with the
assessment.
Functional and clinical assessments
Mobility is assessed by timed get up and go test (TUG)
and Tinetti gait assessment score. TUG starts with an in-
dividual rising from a chair, walking 3 meters, turning
around, returning to the chair, and siting down. TUG test
measures the time taken to complete the test. One practice
trial is given before the test. Results of <10 seconds indi-
cates freely mobile, <20 seconds - mostly independent, 20–
29 seconds - variable mobility, and >20 seconds suggests
impaired mobility. The grading of get up and go (GUG)
[30] is modified into 5 grades in which 1 is normal or no
fall risk and 5 is severely abnormal or very high fall risk.
The Tinetti balance and gait evaluation is divided in two
parts: the first part studies balance defects based on 9 pos-
tural situations and the second part studies gait. The max-
imum score is 28 in which a higher score indicates a better
MCI = Mild cognitive impairment 
Figure 1 Diagnoses of the dementia and disability project (DDP) cohort from the period of 2004–2006. MCI = Mild cognitive impairment.
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(ADLs) are assessed by utilizing the Thai ADL scale which
consists of 6 basic ADLs and 7 instrumental ADLs and
scored as 01, 2. A higher score of Thai ADLs indicates
poorer daily function.
The NPI-Q assesses 12 neuropsychiatric including mood,
psychotic, vegetative, and frontal related symptoms or
behaviors. It starts with asking if the symptom is present
(1= yes, 0= no) and asking about the severity of the symp-
toms (1= mild, 2= moderate, 3=severe). The NPI includes
additional frequency assessment that scoring 1 to 4 (1 =
occasionally, less than once per week; 4 = very frequently,
once or more per day or continuously). The NPI-Q was
used at the screening phase at baseline and the NPI was
used in those who came into the second phase of the study
to assess their dementia and MCI status. Caregivers or fam-
ily members familiar with the individual’s behavior are
interviewed using scripted questions. The caregiver is asked
if the individual’s behavior has changed during the past
month. Thai GDS consists of 30 questions; a higher score
signifies more depressive symptoms. Score 0–12 implies no
depression, score 13–18 suggests mild depression, score
19–20 indicates moderate depression, and score 25–30
denotes severe depression. An individual is asked to con-
sider if the symptoms are present in the past 1 week. The
CDR is a global assessment instrument of dementia that
yields global and sum of boxes (SB) scores, with the global
score being indicative of stage dementia severity while
CDR-SB being considered a more detailed quantitative gen-
eral index than the global score [31]. The CDR assesses 6
domains of functioning: memory, orientation, judgment
and problem solving, community affairs, home and hob-
bies, and personal care. Each domain is rated on a 5-point
scale of functioning as follows: 0, no impairment; 0.5, ques-
tionable impairment; 1, mild impairment; 2, moderateimpairment; and 3, severe impairment (personal care is
scored on a 4-point scale without a 0.5 rating available).
TMSE is a screening tool for cognitive impairment.
Those with TMSE ≤ 26 were recruited to evaluate cogni-
tive status. 5-10% of cognitively normal elderly were
examined (74 cognitively normal elderly, 5.05%). The
DDP is also interested in the association of cognition and
other chronic diseases. Comorbid diseases that are in-
cluded in this study are hypertension (BP≥140/90 mmHg
or on antihypertensive drugs); pulmonary diseases (such
as chronic obstructive pulmonary disease: having history
of chronic progressive symptoms namely cough and/or
wheeze and/or breathlessness with objective evidence of
airways obstruction that does not return to normal with
treatment, taking medication to help ventilation/breathing
problems, asthma, and restrictive lung diseases); heart
disease (coronary heart disease, valvular heart disease, and
heart failure); thyroid diseases (hypothyroidism, hyperthy-
roidism, or taking medication for thyroid); diabetes melli-
tus (taking hypoglycemic drugs, taking regular insulin
injection, or fast blood sugar ≥126 mg%); arthritis (history
of or on examination present osteoarthritis (OA). (OA of
the knee is characterized by knee pain for most days of
the prior month, OA of the hand is characterized by hand
pain, aching or stiffness for most days of the prior month,
OA of the hip with hip pain for most days of the prior
month); crystal induced arthritis, and rheumatoid arth-
ritis); cerebrovascular disease (taking platelet anti aggrega-
tion drugs and a history of previous stroke, having a
history of stroke, or hemiparesis on neurological examin-
ation); smoker (current or active smoking); and alcohol
drinker (current or active alcohol drinking). The World
Health Organization (WHO) defines health as a state of
complete physical, mental, and social well-being, not
merely the absence of disease and has invented a
Table 2 Prevalence of dependence on activity of daily









Bathing 1935(98.9) 12(0.6) 9(0.5)
Dressing 1938(99.1) 12(0.6) 6(0.3)
Toileting 1943(99.1) 6(0.3) 7(0.4)






















Cooking 1839(94) 71(3.6) 46(2.3)





Money handling 1862(95.2) 68(3.5) 26(1.3)
Table 1 Subject baseline characteristics and their blood
test results




Thai ADL scale scores 0.83(2.35)









Sum Thai GDS 9.35(6.65)
Serum B12 (pmol/L) (N=309) 448.85(229.43)













Hemoglobin (gm/dL) (N=319) 12.79(1.89)
Blood pressure (mmHg) 140.46(20)/81.64(10.47)





Marital status: married/ single/
widowed or divorced (N=1960)
1009(51.5)/ 146(7.4)/ 805(41.1)
Levels of education: no formal years
of education/ < 4 years/4 years/ >4-6









Currently still working (N=1966) 1043(53.1)
Levels of income: very poor / not
enough or poor/ sometimes
insufficient/sufficient income/good
income with some saving (N=1938)
60(3.1)/403(20.8)/490(25.3)/809
(41.7)/176(9.1)




TMSE = Thai Mini Mental State Examination ADL = Activity of daily living.
GDS = Geriatric depression scale.
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related to health care. WHO describes Quality of Life
(QoL) [27]as an individual's perception of their position in
life in the context of the culture and value systems in
which they live and in relation to their goals. The
WHOQOL-BREF in this study is based on a four domain
structure: physical health, psychological health, socialrelationships, and environment. The WHOQOL-BREF is
self-administered to elderly individuals with family mem-
bers or caregivers as assistants. Standardized instructions
were read to respondents when the assessment is inter-
viewer-administered. The WHOQOL-BREF initial raw
scores are converting to transformed scores with the sec-
ond transformation converting domain scores to a 0–100
scale. The initial rating score ranges from 1 (very dissatis-
fied, never, not at all, very poor) to 5 (very satisfied, always,
extremely, very good).
Magnetic resonance imaging study
All MCI, dementia, and some cognitively normal elderly
subjects were offered a brain MRI study within 6 months
after the diagnosis of dementia or MCI was made. A total
of 223 subjects had brain MRI. The MRI scan was done
with 1.5T. (Intera, Philips, the Netherlands) field strength.
The protocol composed of 3D-T1wi in coronal plane per-
pendicular to temporal lobe axis (iso-voxel 1×1×1 mm),
axial FLAIR and T2wi (thickness 5 mm). The 3D-T1wi was
reformatted to axial plane and used for volumetric meas-
urement of hippocampus. Axial gradient echo T2wi was
performed in some cases. Visual rating scale of medial tem-
poral lobe area (MTA) [32], Fazekas WML [33], and Schel-
tens WML rating scale (SS) [34] were utilized in brain MRI
reading by radiologist (O. Chawalparit, OC) and neurologist
Table 3 Correlations between ADL (Thai ADL scale scores)
and vascular risk factors or relevant factors




Age (years) 69.51(6.71) 0.305(**)
Weight (kgs) 58.36(11.20) −0.110(**)
TMSE 26.06(3.62) −0.505(**)





































Blood pressure (mmHg) 140.46(20)/81.64
(10.47)
0.054(*)/0.032
Timed get up and go
(TUG) (seconds)
13.22(7.27) 0.397(**)











Levels of income: very































Table 3 Correlations between ADL (Thai ADL scale scores)




















































* = p<0.05 ** = p<0.01.
ADL= Activity of daily living, TMSE= Thai Mini Mental State Exam,
GDS = Geriatric depression scale.
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(ROI) technique was done by OC and VS. VS and OC
obtained rater standardization evaluation with a weighted
kappa variance score <10%. The WMLs were visually rated
on the axial FLAIR image with the use of two semiquantita-
tive rating scales. The Fazekas scale is a four-point scale
(none, mild, moderate, severe) rating the extent and sever-
ity of the deep white matter changes and the Scheltens
scale, in which WMLs are rated 0–6 in 13 subcortical
regions, including the basal ganglia and infratentorial re-
gion, and 0–2 in 3 periventricular regions, resulting in a
total range of 0–84. The global cortical atrophy (GCA) [35]
was rated on the axial FLAIR image using a 4-point visual
rating scale (0 = none, 1 = widening of sulci, 2 = atrophy of
gyri, 3= end stage atrophy with ‘razor-blade’ gyri). The
MTA was visually rated on 3D-T1wi in coronal plane using
a 5-point scale (0 = none, 1 = widening of Choroid fissure,
2 = widening temporal horn, opening fusiform and collat-
eral sulcus, 3 = profound volume loss hippocampus, 4 =
end stage atrophy).
Follow-up assessment
Clinical data on daily function, cognition, and neuro-
psychiatric symptoms were reassessed in MCI, dementia














6 (17.1%) 5 (14.3%) 24 (68.6%) 35 (100%)
No No 2 (25%) 4 (50%) 2 (25%) 8 (100%)
No 165 (62%) 69 (25.9%) 326 (12%) 266 (100%)
Chi square p= 0.044*.
df = 2 (6.229).
Participants who have untreated diabetes mellitus are 37% (25%+12%=37%)
of those elders with abnormal FBS.
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1–2 year interval. In this study the mean follow up time
on 288 subjects is 529.96 days (SD=230.73 days, median
433 days, min 272 days, max 1,312 days). Evolution of
cognitive function especially to a diagnosis of dementia
was assessed at the follow up, by a consensus group
(neurologists, psychologists, radiologist and physicists).Statistical analysis
Statistical analysis was performed using SPSS 11 (SPSS
Inc., Chicago, IL) We examined baseline demograph-
ics, risk factors, and comorbid features by assessing
significance by means of Chi square test for categorical
variables. We assessed the association between activ-
ities of daily living and vascular risk factors or relevant
predictors with Pearson or Spearman correlation coeffi-
cient of the whole data and then performed linear regres-
sion analysis. We assessed the association between WML,
cognitive function and general brain atrophy with Pearson
correlation coefficient. The subjects with MCI or dementia
and cognitively normal elderly were compared across
demographic characteristics (age, sex, education, living con-
ditions, employment status) using t tests. Risk factors of
cognitive decline were compared using one-way ANOVA
with Bonferoni adjustment or Chi square test. Epi info 6
was used to find 95% confidence interval of the prevalence
and odds ratio. P<0.05 is considered to be of statistical
significance.Table 5 Participants who have a history of hypertension and
Normal or well controlled B
History of hypertension (divided into
those with adequate treatment with
good BP controlled (<140/90) and
inadequate treatment with poor BP
controlled (BP>140/90)
Yes 193 (25.6% of those on antihy






Thai elders who have untreated hypertension or have inadequate treatment of hypResults
One thousand nine hundreds and ninety-nine elders
were screened. Only 1973 subjects had adequate data for
statistical analysis. The DDP study summary is shown in
Figure 1 and subject baseline characteristics are shown
in Table 1. 951(48.2%) elders had memory complaints
(considered by either elders or/and caregivers). The
GUG test reveals that 1442 elders (76.9%) had no fall
risk, 225(12%) had low fall risk, 116(6.2%) had some fall
risk, 73(3.9%) had high fall risk, and 18(1%) had very
high fall risk. However, two hundred and one elders
(201/1962=10.24%) reported having falls in the previous
1 month. Regarding Thai ADL assessment scale, 75% of
these Thai elders are independent in IADL, 10.4% had
impairment in 1 IADL, and 14.6% had 2 or more IADL
impairments. The majority of these elders (93.3%) is
independent for basic ADL. 3.9% and 1.2% had 1 and 2
impairment in basic ADL. Prevalence of dependency in
basic and instrumental ADLs is shown in Table 2. Al-
most 4% of this elderly cohort reported having urinal or
fecal incontinence. Nearly 20% of this elders reported
partial or total dependence on travelling or utilizing
public transportation or commuting into a community.
Walking assessment [36] also reveals that the prevalence
of lower level gait disturbance is 20% (395/1952), that of
middle level gait disturbance is 2.6% (52/1952), that of
higher level gait disturbance is 1.5% (29/1952), and the
prevalence of normal gait is 74.8%(1476/1952). In
Table 3, we found fair to moderately good associations
(r=0.25 to r=0.75) between function (activities of daily
living) and age, weight, TMSE, balance and gait mea-
sures (Tinetti balance & gait assessment, TUG). Low
correlations (r<0.25) between function and depression
(Thai GDS), systolic blood pressure, gender, previous
occupation, levels of income, blood levels of homocyst-
eine, history of taking hypnotics, history of having thy-
roid disorders or previous stroke or osteoarthritis/
rheumatoid arthritis or heart disease or diabetes mellitus
or hypertension, and alcohol drinking were discovered.
All significant associations are lost when controlled with
age. A linear regression model to predict performance of
activities of daily living reveals that adjusted R2 is 0.280actually have taken antihypertensive drugs
P (<140/90) High BP (≥140/90) Total
pertensive
BP) 529
560 (74.4% of those on antihypertensive
drugs but having poor controlled BP)
753 (100%)
669 (55.8% of those without a history of
hypertension but having high BP)
1198 (100%)
1229 (63%) 1951 (100%)
ertension (HT) are 63% [(560+669)/1951=62.99%].
Table 6 Comorbidity in Thai elderly cohort
Number of comorbidities Total
0(n, % in row, % in
column)
1(n, % in row, % in
column)
2(n, % in row, % in
column)
3(n, % in row, % in
column)
4(n, % in row, % in
column)
5(n, % in row, % in
column)
6(n, % in row, % in
column)




60-64 219(41.56, 30.81) 175(33.21, 26.16) 92(17.46, 22.49) 31(5.88, 24.22) 9(1.71, 23.08) 0 1(0.19, 100) 527(100, 26.86)
65-69 202(35.88, 28.41) 205(36.41,30.64) 114(20.25, 27.87) 30(5.33, 23.44) 12(2.13, 30.77) 0 0 563(100, 28.70)
70-74 141(32.64, 19.83) 146(33.80,21.82) 100(23.15, 24.45) 30(6.94, 23.44) 12(2.78, 30.77) 3(0.69, 60) 0 432(00, 22.02)
75-79 88(32.23, 12.38) 89(32.60, 13.30) 62(22.71, 15.16) 27(9.89, 21.09) 5(1.83, 12.82) 2(0.73, 40) 0 273(100, 13.91)
80+ 61(36.53, 8.58) 54(32.34, 8.07) 41(24.55, 10.02) 10(5.99, 7.81) 1(0.6, 2.56) 0 0 167(100, 8.61)
Total 711(36.24, 100) 669(34.10,100) 409(20.85, 100) 128(6.52, 100) 39(1.99, 100) 5(0.25, 100) 1(0.05, 100) 1962(100, 100)


















Table 7 ApoE gene status
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0.25(triglyceride levels). Table 4 and 5 shows treatment
gap of DM and hypertension. Simple definition of the
treatment gap is the number of people with a condition
or disease who need treatment for it but who do not get
it or who receive inadequate treatment. We found that
37% of those elders with abnormal Fasting Blood Sugar
(FBS) either did not have hypoglycemic treatment or
knew that they had DM but did not take medication
[Chi square p= 0.044, df = 2 (6.229)] and 63%
[(560+669)/1951] of elders had either under diagnosed
hypertension or inadequate treatment of hypertension
[Chi Square p<0.001, df=1(68.075)]. Table 6 shows fre-
quency of comorbidity in Thai elders. Only 781 (39.5%
of 1964 subjects) were free of comorbid diseases
(e.g. hypertension, pulmonary diseases, heart diseases,
thyroid diseases, DM, arthritis, cerebrovascular disease,
smoker, alcoholic drinker). 668 (34%) had 1 chronic dis-
order, 381 (19.4%) had 2 comorbid diseases, 102 (5.2%)
had 3 comorbid diseases, 28 (1.4%) had 4, 3 (0.2%) had
5, and 1 (0.1%) had 6 comorbid diseases. Table 7 shows
ApoE gene status. 22.85% of this elderly cohort (N=302)
are ApoE4 positive. Table 8 demonstrated the result of
brain MRI WMLs. Ninety percent of Thai community
dwelling elders have WMLs. Of those 90%, 52% have
mild WMLs and 38.6% have moderate to severe white
matter lesions.Discussion
This DDP study is the first attempt in the Thai elderly
population to assess the prevalence of cognitive pro-
blems in association with disability and to follow indivi-
duals with cognitive problem. In this study, a linear
regression adjusting for covariates showed that only gait
and balance and triglycerides were significantlyTable 8 Fazekas score of brain MRI (N=223)
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for the other variables. Other variables that were signifi-
cant before adjustment and fell out of the final model
include advanced age, gender, cognitive function, depres-
sive mood, weight, systolic blood pressure, previous oc-
cupation, levels of income, blood levels of homocysteine,
history of taking hypnotics, history of having thyroid dis-
orders or previous stroke or osteoarthritis/rheumatoid
arthritis or heart disease or diabetes mellitus or hyper-
tension, and alcohol drinking. Our elderly are rather mo-
bile. 75% are independent in IADLs and 93.3% are
independent in basic ADLs. Previous studies also
showed that advance in age, presence of diabetes, stroke,
and depressive symptomatology were independent fea-
tures associated with physical disability. WMLs have been
reported to be associated with selective cognitive function,
mobility, mood, and the loss of independence in old age
populations. In an epidemiological study of Nigerian eld-
erly population, it was found that, according to the six-
item ADL index, the prevalence of physical disability for
people aged 65 was 21.4% [37]. Sixty three percent of the
Thai cohort has at least one chronic disease as a comor-
bidity of dementia. Most have 1–2 chronic diseases. Only
six percent of Thai elders in this study live alone. These
are important points in terms of public planning to re-
assure planners of the magnitude and value of family
members as care-givers. Vascular risk factors contribute
to small vessel diseases and dementia. In our study, 38.6%
of Thai elders who had MRIs have moderate to severe
white matter lesions. These findings indicate the high
prevalence of small vessel diseases on our Thai cohort.
Our study reveals a treatment gap (indicating participants
who have untreated or inadequate treatment) of DM and
hypertension in elderly subject. The treatment gap of
chronic diseases, especially those related to vascular risks
is an important issue for disease prevention. To-date,
there is no disease modifying drug for dementia. A recent
proposal [38] to look at seven modifiable risk factors for
AD (diabetes, midlife hypertension, midlife obesity, smok-
ing, depression, cognitive inactivity or low educational at-
tainment) stated that half of AD cases worldwide are
potentially attributable to these risk factors. A 10 to 25%
reduction in these risk factors could potentially lead to a
reduction of 1.3 to 3 million AD cases. Existence of vascu-
lar risk factors and chronic diseases can lead to falls,
osteoporosis, poor mental health and poor mobility out-
come. From the LADIS study [39], elders with WMLs had
cognitive complaint, psychic complaint, and previous
minor stroke. More motor complaint was found in those
with more WMLs on brain imaging. Our study reaffirms
that Thai elderly population has highest allele frequency
of ApoE 3 gene, which is consistence with previous study
[40]. The frequency of ApoE4 gene is 22.85% in the
current study.
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http://www.biomedcentral.com/1471-2377/13/3Assessment of gait in the elderly is as important as func-
tional assessment. The majority of Thai elders has normal
gait and the second common cause of abnormal gait is
low level gait disorder. The basic neural control of walking
on 2 legs consists of equilibrium, locomotion, and other
non- neurologic factors (mechanical support system and
general health). Abnormal gait syndromes [36] can be
divided into lower level gait disorder (peripheral skele-
tomuscle problems and peripheral sensory problems),
middle level gait disorder (hemiplegic gait, paraplegic gait,
cerebellar ataxic gait, Parkinsonian gait, choreic gait, and
dystonic gait), and highest level gait disorder (cautious
gait, subcortical disequilibrium, frontal disequilibrium,
isolated gait ignition failure, and frontal gait disorder).
Furthermore, neurologic abnormalities affecting gait occur
early in several types of non-Alzheimer's dementias.
Verghese J, et al. found that subjects with neurologic gait
abnormalities had a greater risk of development of demen-
tia (hazard ratio, 1.96 [95 percent confidence interval,
1.30 to 2.96]) [41]. Among the types of abnormal gait, un-
steady gait predicted vascular dementia (hazard ratio,
2.61), as did frontal gait (hazard ratio, 4.32) and hemipare-
tic gait (hazard ratio, 13.13). The importance of deterior-
ation in the control of balance as a reason leading to
abnormal gait in the elderly is well recognized. Assess-
ment of gait problems can be part of fall prevention and
dementia evaluation. Additionally, one contributor of ab-
normal gait is a musculoskeletal issue that is less flexible
and decreasing in strength. Poor motor plan in elderly
individuals is another factor. Thus, we can signify a rela-
tionship between comorbidity and disability.
Once again, this is an initial study on imperative baseline
information and the relations between daily function and
vascular risk factors. Future analysis of the data will be car-
ried out on other issues. The limitation of this study is that
it includes only elderly living in Bangkok Metropolitan
areas. It may not represent the whole country but it is the
first study in Thailand to look at dementia, MCI and
chronic disorders. Our investigation on prevalence of white
matter lesions in community dwelling Thai elders is the
first epidemiologic neuroimaging study in Thailand.
Conclusions
The DDP study offers the possibility of exploring the role
of dementia and functional disabilities in relation to the
evolution of cognitive decline in an ageing Thai population.
The DDP comprises a large and comprehensive test battery
and explores global and selective functions of cognition,
mobility, and daily activity. An epidemiological study of
brain MRI is conducted for the first time in Thai popula-
tion in this study.
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